Misonix and SonoSpine Enter Exclusive Partnership

Misonix Inc. has announced a partnership with SonoSpine LLC, an international neurosurgical practice specializing in ultrasonic spine surgery. Misonix’s ultrasonic devices paired with SonoSpine’s revolutionary approach to spine surgery is expected to accelerate the development and application of next-generation ultrasonic surgery.
 
“Innovation is the key driver in improving patient outcomes. We are proud to collaborate with Misonix as we continue to develop and implement ultrasonic surgical tools and techniques for the spine which dramatically improve patient outcomes,” said Dr. Dilantha B. Ellegala, founder and surgeon-in-chief of SonoSpine. “Misonix and SonoSpine share mutual corporate cultures which are committed to pioneering higher quality health care through technological innovation. This exclusive agreement will align these values to accelerate the development of such technologies. Moreover, our concentrated and unified efforts will promote broader and responsible adoption of these technological advances.”
 
A joint clinical database will support Misonix’s development of next-generation devices while providing critical metrics for SonoSpine’s continued success in improving patient care. Access to SonoSpine’s clinical facilities allows new opportunities for Misonix to engineer from the surgeon’s perspective within the operating suite. To widen the framework of ultrasonic therapies, plans include joint device development, clinical outcomes evaluation, and a shared ultrasonic training facility where key opinion leaders and researchers can meet to fully leverage SonoSpine’s surgical approach and tap into Misonix’s extensive research and product development capabilities.
 
“This strategic partnership that we’ve entered into with Dr. Ellegala and his team at SonoSpine is an important milestone for Misonix. Our engineers and marketing team, working in close concert with the SonoSpine surgeons, will not only create best-in-class ultrasonic surgical instruments, but also collaborate on the development of entirely new surgical procedures and techniques that would otherwise not be possible,” concluded Scott Ludecker, senior vice president of global sales and marketing at Misonix. 

Misonix Inc. designs, develops, manufactures, and markets therapeutic ultrasonic medical devices. Misonix’s therapeutic ultrasonic platform is the basis for several medical technologies. Addressing a combined market estimated to be worth more than $1.5 billion annually, Misonix’s proprietary ultrasonic medical devices are used in spine surgery, neurosurgery, orthopedic surgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications. The company is based in Farmingdale, N.Y.